http://www.bing.com/news/search?q=reddy+pharma&setmkt=en-US&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=reddy+pharma&setmkt=en-US&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.moneycontrol.com%2fnews%2fbusiness%2fnikhil-kamath-s-latest-podcast-offers-look-into-indian-pharma-industry-13953381.html&c=13537152762163530097&mkt=en-usThe latest episode of WTF with Nikhil Kamath features two pharmaceutical leaders - Rajeev Juneja, Co-Founder and Managing Director of Mankind Pharma, and GV Prasad, Co-Chairman and CEO of Dr. Reddy's ...Thu, 18 Jun 2026 08:19:00 GMTMoneycontrolhttp://www.bing.com/th?id=ONUT.c2zYp4sTdhOzHb3vQrD25Q&pid=Newsw={0}&h={1}&c=141280720http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.msn.com%2fen-in%2fhealth%2fother%2fafter-dr-reddy-s-sun-pharma-gets-court-nod-to-export-weight-loss-drug%2far-AA1S5GRv&c=1176448885215737040&mkt=en-usThe Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based weight-loss drugs. Sun Pharma assured the court it will not sell any anti-obesity products in the Indian market ...Wed, 10 Dec 2025 07:25:00 GMTMSNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.businesswire.com%2fnews%2fhome%2f20231214145695%2fen%2fDr.-Reddys-becomes-first-Indian-pharma-company-to-debut-on-the-Dow-Jones-Sustainability-World-Index&c=8402306936743740997&mkt=en-usIn a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the Dow Jones Sustainability Emerging Markets Index for the 8th ...Wed, 13 Dec 2023 23:49:00 GMTBusiness Wirehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.marketwatch.com%2fdata-news%2fdr-reddy-s-laboratories-slips-thursday-underperforms-competitors-f442dd53-1828dc2c9c25&c=11243508245900977705&mkt=en-usDr. Reddy's Laboratories Ltd. closed 7.86% short of its 52-week high of 1,376.00 rupees, which the company reached on April 29th.Thu, 18 Jun 2026 04:10:00 GMTMarketWatchhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.marketwatch.com%2fdata-news%2fdr-reddy-s-laboratories-slips-wednesday-underperforms-market-64fdc0c2-9200836780af&c=18421204267441114658&mkt=en-usDr. Reddy's Laboratories Ltd. 500124 shares inched down 0.63% to 1,269.00 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...Wed, 17 Jun 2026 17:28:00 GMTMarketWatchhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2ftelanganatoday.com%2ftag%2fdr-reddys-laboratories&c=7191342536196524201&mkt=en-usGet Dr Reddy’s Laboratories News on Telangana Today, Dr Reddy’s Laboratories latest news, Dr Reddy’s Laboratories news, | Telangana Today ...Sun, 14 Jun 2026 20:07:00 GMTTelangana Todayhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fdr-reddy-s-laboratories-ltd-and-merck-serono-announce-collaboration-to-develop-and&c=9782948093415972546&mkt=en-usCombined expertise of Dr. Reddy's and Merck Serono to deliver on promise of Biosimilars HYDERABAD, India, Jun 06, 2012 (BUSINESS WIRE) -- Dr. Reddy's Laboratories Ltd. and Merck Serono, a division of ...Wed, 06 Jun 2012 03:49:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.cnbc.com%2f2012%2f10%2f08%2fdr-reddys-custom-pharmaceutical-services-cps-business-expands-its-manufacturing-operations-in-mirfield-uk.html&c=4581103014380067612&mkt=en-usHYDERABAD, India--(BUSINESS WIRE)-- The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced expansion in the areas of activated mPEG ...Mon, 08 Oct 2012 05:54:00 GMTCNBChttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma-asia%2fdr-reddy-s-enters-u-s-consumer-health-market-through-ducere-pharma-deal&c=10548651511924780507&mkt=en-usDr. Reddy’s Laboratories ($RDY) has acquired a portfolio of 6 over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories as it looks to ...Wed, 25 May 2016 00:01:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.businesswire.com%2fnews%2fhome%2f20220624005239%2fen%2fDr.-Reddys-Laboratories-Announces-the-Acquisition-of-an-Injectable-Product-Portfolio-from-Eton-Pharma&c=18441736992681170472&mkt=en-usHYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.Fri, 24 Jun 2022 02:09:00 GMTBusiness Wirehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.mmm-online.com%2fhome%2fchannel%2fdr-reddys-picks-up-mayne-pharmas-111m-u-s-generics-portfolio%2f&c=2506734378573563399&mkt=en-usDr. Reddy’s Laboratories announced Monday morning that it has reached an agreement with Mayne Pharma to acquire its U.S. generic prescription product portfolio. As part of the deal, Dr. Reddy’s adds ...Sun, 26 Feb 2023 16:00:00 GMTMM&Mhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34a04309c84f88ac336d67fce51ec6&url=https%3a%2f%2fwww.nasdaq.com%2fpress-release%2fdr.-reddys-becomes-first-indian-pharma-company-to-debut-on-the-dow-jones&c=9328483600221786734&mkt=en-usHYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, has ...Thu, 14 Dec 2023 05:37:00 GMTNasdaq